HER2-positive breast cancer: What is it? - Mayo Clinic
2024年4月9日 · HER2-positive breast cancer is a breast cancer that tests positive for a protein called human epidermal growth factor receptor 2 (HER2). This protein promotes the growth of cancer cells. In about 1 of every 5 breast cancers, the cancer cells have extra copies of the gene that makes the HER2 protein.
Breast cancer types: What your type means - Mayo Clinic
2024年10月31日 · HER2 positive. Breast cancer cells that make a lot of extra HER2 protein are called HER2 positive. Targeted therapy treatments with medicine that hurts cells making too much HER2 can help control this kind of breast cancer. HER2 low. Breast cancer is called HER2 low if some of the cancer cells show signs of making extra HER2.
Trastuzumab (intravenous route) - Mayo Clinic
2024年8月1日 · Trastuzumab injection is also used in combination with cisplatin and capecitabine or 5-fluorouracil to treat HER2-overexpressing metastatic (cancer that has spread) stomach and gastroesophageal (stomach and esophagus) cancer. Trastuzumab prevents the growth of some tumors that produce extra amounts of a certain substance known as the HER2 protein.
Cáncer de mama positivo para HER2: ¿qué es? - Mayo Clinic
2024年4月9日 · HER2-positivo tienden a ser más agresivos que otros tipos de cáncer de mama. Los tratamientos dirigidos específicamente al HER2 son muy efectivos. Estos tratamientos son tan efectivos que el pronóstico para cáncer HER2-positivo con HER2 es …
Vaccine study for HER2-positive breast cancer moves forward
2019年3月1日 · Trastuzumab works by activating the immune system's B cells, which look for and attack breast tumor cells with HER2 proteins on the surface. The new vaccine also stimulates another group of cells in the immune system — long-lasting T cells that remember the proteins and promote resistance to recurrence.
Recurrent breast cancer - Symptoms and causes - Mayo Clinic
2024年4月19日 · If your cancer makes extra HER2 protein, drugs that target that protein can help decrease the chance of the cancer recurring. Bone-building drugs. Taking bone-building drugs reduces the risk of cancer recurring in the bones (bone metastasis) in people with an increased risk for breast cancer recurrence. Maintaining a healthy weight.
سرطان الثدي الإيجابي HER2: ما هو؟ - Mayo Clinic (مايو كلينك)
سرطان الثدي إيجابي البروتين her2 هو سرطان ثدي يعطي تشخيصُه نتيجة إيجابية لبروتين يسمى "مُستقبِل عامل نمو البشرة 2 لدى البشر"، و her2 هي اختصار لهذا الاسم. يحفز هذا البروتين نمو الخلايا السرطانية.
BRCA gene test for breast and ovarian cancer risk - Mayo Clinic
2023年10月21日 · Overview. The BRCA gene test looks for DNA changes that increase the risk of breast cancer and ovarian cancer. It uses a sample of blood or saliva to look for the changes.
Recurrent breast cancer - Diagnosis and treatment - Mayo Clinic
2024年4月19日 · If testing shows your cancer cells produce excess HER2 protein, medications that target that protein will likely be recommended. Treating a regional recurrence. Treatments for a regional breast cancer recurrence include: Surgery. If it's possible, surgery to remove the cancer is the recommended treatment for a regional recurrence.
Chemotherapy for breast cancer - Mayo Clinic
2024年10月23日 · If your breast cancer produces too much of a growth-promoting protein known as HER2, your doctor may recommend chemotherapy and drugs that specifically target this protein. Genetic profile. For certain types of breast cancer such as hormone receptor positive breast cancer, your doctor may have your cancer cells tested to learn more about their ...